MDS	myelodysplastic syndrome
BDH2	type 2-hydroxybutyrate dehydrogenase
BM	bone marrow
qRT-PCR	quantitative real-time polymerase chain reaction
BDH2-KD	BDH2 knockdown
AML	acute myeloid leukemia
RUNX1	runt-related transcription factor 1
c-CBL	c-Casitas B-lineage lymphoma
DNMT3A	DNA methyltransferase 3 alpha
TET2	tet methylcytosine dioxygenase 2
EZH2	enhancer of zeste homolog 2
U2AF1	U2 small nuclear RNA auxiliary factor 1
U2AF35	U2 small nuclear RNA auxiliary factor 35
ZRSR2	zinc finger CCCH type, RNA binding motif, and serine/arginine-rich 2
SRSF2	serine and arginine-rich splicing factor 2
SF3B	splicing factor 3b subunit 1
GDF11	growth differentiation factor-11
GDF15	growth differentiation factor-15
LFS	Leukemia-free survival
OS	overall survival
LCN2	lipocalin 24p3
2,5-DHBA	2,5-dihydroxybenzoic acid
WHO	World Health Organization
IPSS-R	Revised International Prognostic Scoring System
RA	refractory anemia
RARS	refractory anemia with ring sideroblast
RAEB1	refractory anemia with excess of blast 1
RAEB2	refractory anemia with excess of blast 2
MDS/MPN	myelodysplasitic syndrome/myeloproliferative neoplasm
NNT	nicotinamide nucleotide transhydrogenase
TCA	tricarboxylic acid
SLC25A1	solute carrier 25 A1
BBF2H7/CREB3L2	CAMP responsive element binding protein 3 like 2
ER	endoplasmic reticulum
TGF-β	transforming growth factor-β
MMP-9	Matrix metalloproteinase-9
PIK3CD	Phosphoinositide-3-kinase, catalytic, delta polypeptide
TNFSF13B	tumor necrosis factor superfamily member 13B
IL	interleukin
CCL	Chemokine ligand
PRL	prolactin